Skip to content
Disclosery

EXANE DERIVATIVES: CIBR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CIBR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 13,736 CIBR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 13,736 shares
    Change vs previous 13F -8,257 shares

    0.32% of the 13F portfolio, value $552,624.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 21,993 shares
    Change vs previous 13F +18,243 shares

    0.33% of the 13F portfolio, value $1,167,976.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,750 shares
    Change vs previous 13F -3,750 shares

    0.05% of the 13F portfolio, value $197,955.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 7,500 shares
    Change vs previous 13F 0 shares

    0.09% of the 13F portfolio, value $365,387.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 7,500 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $358,642.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).